BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹42 Cr | ₹36 Cr | ₹31 Cr | ₹25 Cr | ₹12 Cr |
What is the latest Consolidated Net Profit of BETA DRUGS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹36 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹12 Cr |
How is Consolidated Net Profit of BETA DRUGS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | 16.42 | |
| Mar2024 | ₹36 Cr | 18.61 | |
| Mar2023 | ₹31 Cr | 23.73 | |
| Mar2022 | ₹25 Cr | 111.75 | |
| Mar2021 | ₹12 Cr | - | |
Compare Consolidated Net Profit of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,390.3 Cr | -1.4% | 46.3% | 17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -1.4% |
46.3% |
17.7% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses